https://doi.org/10.4081/reumatismo.2009.107

Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

Vol. 61 No. 2 (2009)
Abstract Views: 1818
PDF: 1068
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

R. Scrivo
office@pagepress.org
F. Conti
F.R. Spinelli
S. Truglia
L. Magrini
M. Di Franco
F. Ceccarelli
G. Valesini
The treatment of rheumatoid arthritis (RA) has evolved over the past decade with the introduction of anti-tumor necrosis factor (TNF) α agents, which allowed remarkable advances in controlling signs and symptoms of inflammation and in slowing joint destruction (1-3). However, some patients do not respond or show suboptimal response to the currently available anti- TNFα agents (infliximab, etanercept, and adalimumab) used either as monotherapy or in combination with methotrexate. Furthermore, patients who respond initially may lose efficacy over time (4) or develop adverse events.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Scrivo, R., Conti, F., Spinelli, F., Truglia, S., Magrini, L., Di Franco, M., … Valesini, G. (2009). Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature. Reumatismo, 61(2), 107–117. https://doi.org/10.4081/reumatismo.2009.107

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.